Elias Campo

Professor Elías Campo Güerri, MD, PhD, is a world-renowned pathologist and biomedical scientist whose research has significantly advanced the genomic understanding and clinical management of lymphoid neoplasms. He is Professor of Pathology at the University of Barcelona and serves as Research Director and Senior Consultant at the Hospital Clínic de Barcelona and the IDIBAPS – August Pi i Sunyer Biomedical Research Institute.
Professor Campo’s scientific work focuses on elucidating the molecular and genetic mechanisms that underlie chronic lymphocytic leukemia (CLL), mantle cell lymphoma, diffuse large B-cell lymphoma, and other aggressive lymphomas. His laboratory has led high-impact genome and epigenome studies within the International Cancer Genome Consortium and co-directed the Spanish CLL genome project, producing foundational maps of disease-specific genomic alterations with direct implications for diagnosis, prognosis, and targeted therapy.
He has been a highly cited researcher since 2015 and has published extensively in leading journals such as Nature Genetics, Nature Medicine, and Blood, contributing new disease classifications, biomarkers, and therapeutic targets in hematologic oncology. Professor Campo has also served in leadership roles including President of the European Association of Hematopathology and membership on the WHO classification committee for haematological neoplasms.
Among his many honours, he was elected a member of the United States National Academy of Medicine in 2018—one of the highest international recognitions for contributions to medical science and global health. He has also received major awards including the Catalan National Research Prize and the Rey Jaime I Prize for Medical Research.
Professor Campo’s work exemplifies the integration of molecular pathology, genomic science, and clinical innovation in addressing complex hematologic diseases, and his leadership continues to shape international research and precision cancer care.